巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    ENDRA Life Sciences

    NDRA
    0.229
    0.010
    4.98%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・ENDRA Life Sciences - 延遲價格・最後更新於 20/05 12:15
    最高位
    0.234
    最低位
    0.220
    開市價
    --
    前收市價
    0.241
    成交量(千)
    26.78
    成交額(百萬)
    0.06
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    14.46
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    2.440 - 0.180
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    ENDRA Life Sciences
    證券代碼
    NDRA.US
    所屬板塊
    Diagnostics & Research
    公司業務
    ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
    發行量
    42165726
    公司總部
    3600 Green Court, Suite 350
    公司網址
    https://www.endrainc.com
    公司電話
    +1 734 335-0468
    暫無內容

    關於

    ENDRA Life Sciences(NDRA.US)所屬的行業板塊為Diagnostics & Research。
    ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.
    詳細公司背景可參考: https://www.endrainc.com